Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Oct 20, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹9.8451+0.5% 1 day change | -1.62% | App exclusive | ₹614 Cr |
| AUM (Fund size) | ₹614 Cr |
| Exit load | 1.0% Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.! |
| Lock-in Period | Nil |
| Age | 4 m since Jun 09, 2025 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹1000 & Lumpsum: ₹5000 |
| Expense ratio | 2.28% as on Sep 30, 2025 |
| Plan type | Regular |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | 2.2% | 2.15% |
| 3 Months | -2.51% | -0.73% |

Large Cap 50.39%
Mid Cap 17.24%
Small Cap 27.14%
Other Cap 0%
Healthcare 91.96%
Insurance 2.81%
Bifurcation by Credit Quality is not available for this fund
Others 7.88%
CBLO 7.88%
Bifurcation by Holding is not available for this fund

| Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | 2.2% | N.A. | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 1.8% | 9.49% | 7.55% | 27.92% | 20.98% | 15.16% |
| SBI Healthcare Opportunities Fund | 2.93% | 5.7% | 7.57% | 25.5% | 20.14% | 11.0% |
| DSP Healthcare Fund | 2.27% | 6.86% | 0.02% | 22.71% | 18.11% | 14.77% |
| Tata India Pharma & Healthcare Fund | 1.98% | 6.5% | 2.98% | 22.6% | 18.43% | 11.98% |
| Nippon India Pharma Fund | 1.55% | 4.62% | 2.0% | 21.83% | 18.23% | 12.7% |
| Fund name | Std. deviation | Beta | Sharpe | Sortino |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.66 | 0.95 | 1.2 | 1.74 |
| SBI Healthcare Opportunities Fund | 14.07 | 0.84 | 1.19 | 1.86 |
| DSP Healthcare Fund | 14.67 | 0.84 | 1.03 | 1.8 |
| Tata India Pharma & Healthcare Fund | 16.05 | 0.97 | 0.92 | 1.47 |
| Nippon India Pharma Fund | 15.22 | 0.91 | 0.9 | 1.39 |
| Fund name | ETM Rank | AUM | Fund age | Expense ratio |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | N.A. | 614 Cr | 4 m | 2.28% |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,227 Cr | 7 yrs 4 m | 1.87% |
| SBI Healthcare Opportunities Fund | N.A. | 3,933 Cr | 26 yrs 4 m | 1.93% |
| DSP Healthcare Fund | N.A. | 3,074 Cr | 6 yrs 11 m | 1.93% |
| Tata India Pharma & Healthcare Fund | N.A. | 1,296 Cr | 9 yrs 10 m | 2.1% |
| Nippon India Pharma Fund | N.A. | 8,114 Cr | 21 yrs 5 m | 1.82% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
| Fund AUM | 614 Cr as on Sep 30, 2025 |
| Scheme document | View Scheme Document |
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
| No. of schemes | 41 view all schemes |
| Total AUM | 50,753 Cr as on Sep 30, 2025 |
| Address | BNP Paribas House, 7th Floor, G-Block, Bandra Kurla Complex, Bandra Mumbai, 400051 |
| Phone | 022-33704000 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| Baroda BNP Paribas Midcap Fund | N.A. | 2,190 Cr | 3.29% | 24.6% |
| Baroda BNP Paribas Multi Cap Fund | N.A. | 2,956 Cr | 3.47% | 23.88% |
| Baroda BNP Paribas Large & Mid Cap Fund | N.A. | 1,607 Cr | 1.64% | 21.83% |
| Baroda BNP Paribas India Consumption Fund | N.A. | 1,530 Cr | 3.42% | 20.29% |
| Baroda BNP Paribas Banking and Financial Services Fund | N.A. | 305 Cr | 14.37% | 19.4% |
| Baroda BNP Paribas ELSS Tax Saver Fund | N.A. | 896 Cr | 5.5% | 18.36% |
The current Net Asset Value (NAV) of the Baroda BNP Paribas Health and Wellness Fund plan is approximately ₹9.8451 as of Oct 20, 2025.
The Baroda BNP Paribas Health and Wellness Fund has an expense ratio of 2.28%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Baroda BNP Paribas Health and Wellness Fund currently has assets under management (AUM) or fund size valued at approximately 614 Cr as on Sep 30, 2025.
The Baroda BNP Paribas Health and Wellness Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.64% |
| Divi's Laboratories Ltd. | 7.64% |
| Mankind Pharma Ltd. | 7.53% |
| Apollo Hospitals Enterprise Ltd. | 6.03% |
| Max Healthcare Institute Ltd. | 5.44% |
| Cipla Ltd. | 5.44% |
| Abbott India Ltd. | 4.29% |
| Aster DM Healthcare Ltd. | 4.08% |
| Torrent Pharmaceuticals Ltd. | 3.81% |
| Astrazeneca Pharma India Ltd. | 3.33% |
The Baroda BNP Paribas Health and Wellness Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 91.96% |
| Insurance | 2.81% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the Baroda BNP Paribas Health and Wellness Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
